HFCAS OpenIR

浏览/检索结果: 共2条,第1-2条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文
BMC CANCER, 2023, 卷号: 23
作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping;  Hao, Weiyuan
收藏  |  浏览/下载:10/0  |  提交时间:2023/11/10
Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival  
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Wu, Xin;  Feng, Hao;  Gao, Shujun;  Feng, Hua;  Diao, Wenjing;  Zhang, Hongwei;  Du, Ming;  Lou, Weihua;  Wang, Xipeng;  Zhu, Tao;  Zhang, Yuyang;  Hu, Weiguo;  Xue, Xiaohong;  Zhu, Zhiling;  Xiang, Libing;  Li, Jiarui;  Fang, Xuhong;  Bai, Yongrui;  Hou, Yanli;  Yan, Weili;  Qiu, Ling;  Yu, Hailin;  Zhu, Shurong;  Du, Yan;  Jiang, Hua
收藏  |  浏览/下载:52/0  |  提交时间:2022/05/16
Cervical cancer  Stage IA1 with LVSI and IA2  Laparoscopic radical hysterectomy  Abdominal radical hysterectomy  Progression-free survival  Overall survival  Prognosis